On 14 september 2018, the Netherlands X-omics Initiative had their consortium kick-off meeting. Consortium members from the Dutch partners involved gathered to get to know each other and to determine the next steps to start up the project.Introductions on the different aspects of the project provided insight in the state-of-the-art of current Dutch research facilities and technologies in the areas of genomics, proteomics, metabolomics and data integration & analysis. Subsequent break-out sessions led to fruitful discussions and the first plans of action to realize the Netherlands X-omics initiative.
The Netherlands X-omics Initiative received 17,3M euro funding from the NWO large scale scientific infrastructure program and is coordinated by Alain van Gool of the Radboudumc. The goals of the X-omics project are to push the technological boundaries of the individual omics technologies and to realize a genuinly integrated X-omics infrastructure. See www.x-omics.nl.
Related news items
A personal touch of Antonio Castro18 October 2018
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Antonio Castro.read more
Mark van den Boogaard received the Dr. Peter Moleman penning18 October 2018
Last week Mark van den Boogaard received the Dr. Peter Moleman penning for best article in the field of psycho-pharmacy published in the last 2 years.read more
Symposium Medical care for people with intellectual disabilities18 October 2018
On Tuesday 4 December Esther Bakker will defend her thesis ‘A Pro-active health assessment instrument for people with intellectual disabilities – towards reducing health inequities’. Prior to her defense, a symposium will be held.read more
Very few similarities between the brains of schizophrenia patients Research at group level says little about the individual patient16 October 2018
Patients with a diagnosis of schizophrenia are a heterogenous group with large differences between individuals. Researchers at the Radboudumc showed that only a negligible number of identical features in the brain occur in more than two percent of patients.read more